2009
DOI: 10.1177/0003319709337305
|View full text |Cite
|
Sign up to set email alerts
|

The Functional Promoter Polymorphism of the Coagulation Factor XII Gene is not Associated With Peripheral Arterial Disease

Abstract: Coagulation factor XII (FXII) plays a key role in both coagulation and fibrinolysis and has been associated with cardiovascular disease in some studies. Plasma FXIIa levels are strongly determined by a common functional polymorphism in the promoter of the FXII gene (F12-4C>T). To investigate the potential association of this polymorphism with peripheral arterial disease (PAD), we performed a case-control study including 668 patients with PAD and 762 controls participants without cardiovascular disease. F12 gen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
1
1
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 26 publications
(20 reference statements)
0
2
0
Order By: Relevance
“…118 Furthermore, several studies did not observe an effect of the polymorphism on arterial thrombosis. [119][120][121][122][123] The association of the −4C/T polymorphism and arterial thrombosis is influenced by cholesterol levels. Pravastatin treatment reduced the risk of CAD in men with a CC or CT genotype, but not in men with a TT genotype.…”
Section: Factor XIImentioning
confidence: 99%
“…118 Furthermore, several studies did not observe an effect of the polymorphism on arterial thrombosis. [119][120][121][122][123] The association of the −4C/T polymorphism and arterial thrombosis is influenced by cholesterol levels. Pravastatin treatment reduced the risk of CAD in men with a CC or CT genotype, but not in men with a TT genotype.…”
Section: Factor XIImentioning
confidence: 99%
“…The TT-genotype was associated with an increased risk of CAD in men with high cholesterol [115] and with both CAD and ischemic stroke in the Spanish population [116,117]; however, in patients with pre-existing CAD the TTgenotype had a protective effect on the development of ACS [118]. Furthermore, several studies did not observe an effect of the polymorphism on arterial thrombosis [119][120][121][122][123].…”
Section: Factor XIImentioning
confidence: 99%